Page 50 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 50
CHAPTER 1 The Etiology of Cancer 29
129. Thomas R, Duke SE, Wang HJ, et al.: ‘Putting our heads together’: 151. Hackshaw AK, Law MR, Wald NJ: The accumulated evidence on
insights into genomic conservation between human and canine lung cancer and environmental tobacco smoke, Br Med J 315:980–
intracranial tumors, J Neurooncol 94:333–349, 2009. 988, 1997.
VetBooks.ir 130. Mani RS, Chinnaiyan AM: Triggers for genomic rearrangements: 152. Reif JS, Dunn K, Ogilvie GK, et al.: Passive smoking and canine
lung cancer risk, Am J Epidemiol 135:234–239, 1992.
insights into genomic, cellular and environmental influences, Nat
Rev Genet 11:819–829, 2010.
between environmental factors including second-hand smoke and
131. Modiano JF, Breen M, Burnett RC, et al.: Distinct B-cell and T-cell 153. Zierenberg-Ripoll A, Pollard RE, Stewart SL, et al.: Association
lymphoproliferative disease prevalence among dog breeds indicates primary lung cancer in dogs, J Small Anim Pract 59:343–349,
heritable risk, Cancer Res 65:5654–5661, 2005. 2018.
132. Shearin AL, Hedan B, Cadieu E, et al.: The MTAP-CDKN2A 154. Reif JS, Bruns C, Lower KS: Cancer of the nasal cavity and para-
locus confers susceptibility to a naturally occurring canine cancer, nasal sinuses and exposure to environmental tobacco smoke in pet
Cancer Epidemiol Biomarkers Prev 21:1019–1027, 2012. dogs, Am J Epidemiol 147:488–492, 1998.
133. Tonomura N, Elvers I, Thomas R, et al.: Genome-wide association 155. Herrinton LJ, Friedman GD:Cigarette smoking and risk of non-
study identifies shared risk loci common to two malignancies in Hodgkin’s lymphoma subtypes, Cancer Epidemiol Biomarkers 7:25–
golden retrievers, PLoS Genet 11:e1004922, 2015. 28, Prev1998.
134. Megquier K, Tonomura N, Fall T, et al.: Analyzing GWAS data 156. Linet MS, McLaughlin JK, Hsing AW, et al.: Is cigarette smoking
for disease modifiers in 200 cases of hemangiosarcoma in the golden a risk factor for non-Hodgkin’s lymphoma or multiple myeloma?
retriever, Cambridge, U.K., 2015, International Conference on Results from the Lutheran brotherhood cohort study, Leuk Res
Advances in Canine and Feline Genomics and Inherited Diseases. 16:621–624, 1992.
135. Arendt ML, Melin M, Tonomura N, et al.: Genome-wide asso- 157. Bertone ER, Snyder LA, Moore AS: Environmental tobacco smoke
ciation study of golden retrievers identifies germ-line risk factors and risk of malignant lymphoma in pet cats, Am J Epidemiol
predisposing to mast cell tumours, PLoS Genet 11:e1005647, 2015. 156:268–273, 2002.
136. Truve K, Dickinson P, Xiong A, et al.: Utilizing the dog genome 158. Freedman DS, Tolbert PE, Coates R, et al.: Relation of cigarette
in the search for novel candidate genes involved in glioma develop- smoking to non-Hodgkin’s lymphoma among middle-aged men,
ment-genome wide association mapping followed by targeted mas- Am J Epidemiol 148:833–841, 1998.
sive parallel sequencing identifies a strongly associated locus, PLoS 159. Marconato L, Leo C, Girelli R, et al.: Association between waste
Genet 12:e1006000, 2016. management and cancer in companion animals, J Vet Intern Med
137. Scott MC, Sarver AL, Gavin KJ, et al.: Molecular subtypes of osteo- 23:564–569, 2009.
sarcoma identified by reducing tumor heterogeneity through an 160. Bertone ER, Snyder LA, Moore AS: Environmental and lifestyle
interspecies comparative approach, Bone 49:356–367, 2011. risk factors for oral squamous cell carcinoma in domestic cats, J Vet
138. Scott MC, Sarver AL, Tomiyasu H, et al.: Aberrant retinoblastoma Intern Med 17:557–562, 2003.
(RB)-E2F transcriptional regulation defines molecular phenotypes 161. Snyder LA, Bertone ER, Jakowski RM, et al.: p53 expression and
of osteosarcoma, J Biol Chem 290:28070–28083, 2015. environmental tobacco smoke exposure in feline oral squamous cell
139. Gorden BH, Kim JH, Sarver AL, et al.: Identification of three carcinoma, Vet Pathol 41:209–214, 2004.
molecular and functional subtypes in canine hemangiosarcoma 162. Gibbons DL, Byers LA, Kurie JM: Smoking, p53 mutation, and
through gene expression profiling and progenitor cell characteriza- lung cancer, Mol Cancer Res 12:3–13, 2014.
tion, Am J Pathol 184:985–995, 2014. 163. Hecht SS: Lung carcinogenesis by tobacco smoke, Int J Cancer
140. Elvers I, Turner-Maier J, Swofford R, et al.: Exome sequencing of 131:2724–2732, 2012.
lymphomas from three dog breeds reveals somatic mutation patterns 164. Scesnaite A, Jarmalaite S, Mutanen P, et al.: Similar DNA methyla-
reflecting genetic background, Genome Res 25:1634–1645, 2015. tion pattern in lung tumours from smokers and never-smokers with
141. Wang G, Wu M, Maloneyhuss MA, et al.: Actionable mutations in second-hand tobacco smoke exposure, Mutagenesis 27:423–429,
canine hemangiosarcoma, PLoS One 12:e0188667, 2017. 2012.
142. Sakthikumar S, Elvers I, Kim J, et al.: SETD2 is recurrently 165. Hayes HM, Tarone RE, Cantor KP, et al.: Case-control study of
mutated in whole-exome sequenced canine osteosarcoma, Cancer canine malignant lymphoma: positive association with dog owner’s
Res 78:3421–3431, 2018. use of 2,4-dichlorophenoxyacetic acid herbicides, J Natl Cancer Inst
143. JU Pontius, Mullikin JC, Smith DR, et al.: Initial sequence and 83:1226–1231, 1991.
comparative analysis of the cat genome, Genome Res 17:1675– 166. Carlo GL, Cole P, Miller AB, et al.: Review of a study reporting
1689, 2007. an association between 2,4-dichlorophenoxyacetic acid and canine
144. Thomas R, Valli VE, Ellis P, et al.: Microarray-based cytogenetic malignant lymphoma: report of an expert panel, Regul Toxicol Phar-
profiling reveals recurrent and subtype-associated genomic copy macol 16:245–252, 1992.
number aberrations in feline sarcomas, Chromosome Res 17:987– 167. Hayes HM, Tarone RE, Cantor KP: On the association between
1000, 2009. canine malignant lymphoma and opportunity for exposure to
145. Modiano JF, Breen M: Shared pathogenesis of human and canine 2,4-dichlorophenoxyacetic acid, Environ Res 70:119–125, 1995.
tumors - an inextricable link between cancer and evolution, Cancer 168. Kaneene JB, Miller R: Re-analysis of 2,4-D use and the occurrence
Therapy 6:239–246, 2008. of canine malignant lymphoma, Vet Hum Toxicol 41:164–170,
146. Carcinogens report adds seven agents, Cancer Discov 7(5), 2017. 1999.
147. NTP (National Toxicology Program): Report on Carcinogens, ed 14, 169. Reynolds PM, Reif JS, Ramsdell HS, et al.: Canine exposure to
Research Triangle Park, NC, 2016, U.S. Department of Health and herbicide-treated lawns and urinary excretion of 2,4-dichloro-
Human Services, Public Health Service. phenoxyacetic acid, Cancer Epidemiol Biomarkers Prev 3:233–237,
148. World Health Organization: WHO Report on the Global Tobacco 1994.
Epidemic, The MPOWER package, Geneva, 2008, World Health 170. Gavazza A, Presciuttini S, Barale R, et al.: Association between
Organization. canine malignant lymphoma, living in industrial areas, and use of
149. DeVita VT, Lawrence TS, Rosenberg SA: Devita, Hellman, and chemicals by dog owners, J Vet Intern Med 15:190–195, 2001.
Rosenberg’s cancer: principles & practice of oncology, ed 10, Philadel- 171. Takashima-Uebelhoer BB, Barber LG, Zagarins SE, et al.: House-
phia, 2015, Wolters Kluwer. hold chemical exposures and the risk of canine malignant lym-
150. Leonard CT: Environmental tobacco smoke and lung cancer inci- phoma, a model for human non-Hodgkin’s lymphoma, Environ
dence, Curr Opin Pulm Med 5:189–193, 1999. Res 112:171–176, 2012.